NALOXONE AGUETTANT 0,4 mg/ml, solution injectable
solution injectable
intramusculaire;intraveineuse;sous-cutanée
Autorisation active
Procédure nationale
Commercialisée
6/21/2005
AGUETTANT
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!